Unrecognized myocardial infarction assessed by cardiac magnetic resonance imaging -prognostic implications

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Nordenskjöld, Anna M ^a   Hammar, Per ^b   Ahlström, Håkan ^c   Bjerner, Tomas ^c   Duvernoy, Olov ^c   Eggers, Kai M ^c   Fröbert, Ole ^a   Hadziosmanovic, Nermin ^d   Lindahl, Bertil ^c  

^a Örebro University   (Sweden)

^b Västmanland s Hospital Västerås   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE OUTCOME; AGE; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DEATH; DISEASE SEVERITY; FEMALE; HEART ARREST; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTION; PROGNOSIS; RISK FACTOR; UNRECOGNIZED MYOCARDIAL INFARCTION; BIOASSAY; CLINICAL TRIAL; COMPLICATION; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PROCEDURES; STATISTICAL MODEL;

AGED; CORONARY ARTERY DISEASE; ENDPOINT DETERMINATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PREVALENCE; PROGNOSIS;

EID: 84960516971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0148803     Document Type: Article

References (33)

1. Pride YB, Piccirillo BJ, Gibson CM. Prevalence, consequences, and implications for clinical trials of unrecognized myocardial infarction. Am J Cardiol. 2013; 111: 914-918. doi: 10.1016/j.amjcard.2012. 11.042 PMID: 23276472
2. Boland LL, Folsom AR, Sorlie PD, Taylor HA, Rosamond WD, Chambless LE, et al. Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study). Am J Cardiol. 2002; 90: 927-931. PMID: 12398956
3. Schelbert EB, Cao JJ, Sigurdsson S, Aspelund T, Kellman P, Aletras AH, et al. Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults. JAMA. 2012; 308: 890-896. doi: 10.1001/2012.jama.11089 PMID: 22948699
4. Kehl DW, Farzaneh-Far R, Na B, Whooley MA. Prognostic value of electrocardiographic detection of unrecognized myocardial infarction in persons with stable coronary artery disease: Data from the Heart and Soul Study. Clin Res Cardiol. 2011; 100: 359-366. doi: 10.1007/s00392-010-0255-2 PMID: 21103882
5. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006; 113: 2733-2743. PMID: 16754804
6. Kim HW, Klem I, Shah DJ, Wu E, Meyers SN, Parker MA, et al. Unrecognized non-Q-wave myocardial infarction: Prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med. 2009; 6: E1000057. doi: 10.1371/journal.pmed.1000057 PMID: 19381280
7. Kwong RY, Korlakunta H. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Top Magn Reson Imaging. 2008; 19: 15-24. doi: 10.1097/RMR. 0B013e31817d550c PMID: 18690157
8. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001; 357: 21-28. PMID: 11197356
9. Barbier CE, Bjerner T, Johansson L, Lind L, Ahlstrom H. Myocardial scars more frequent than expected: Magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006; 48: 765-771. PMID: 16904547
10. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: Comparison with dobutamine stress echocardiography. Circulation. 1999; 99: 763-770. PMID: 9989961
11. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet. 2003; 361: 374-379. PMID: 12573373
12. Barbier CE, Nylander R, Themudo R, Ahlstrom H, Lind L, Larsson EM, et al. Prevalence of unrecognized myocardial infarction detected with magnetic resonance imaging and its relationship to cerebral ischemic lesions in both sexes. J Am Coll Cardiol. 2011; 58: 1372-1377. doi: 10.1016/j.jacc.2011.06. 028 PMID: 21920267
13. Turkbey EB, Nacif MS, Guo M, McClelland RL, Teixeira PB, Bild DE, et al. Prevalence and Correlates of Myocardial Scar in a US Cohort. JAMA. 2015; 314: 1945-1954. doi: 10.1001/jama.2015.14849 PMID: 26547466
14. Hammar P, Nordenskjöld AM, Lindahl B, Duvernoy O, Ahlström H, Johansson L, et al. Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery. Journal of Cardiovascular Magnetic Resonance. 2015; 17: 98. doi: 10.1186/s12968-015-0202-5 PMID: 26585508
15. Nordenskjold AM, Ahlstrom H, Eggers KM, Frobert O, Venge P, Lindahl B. Short-and long-term individual variation in NT-proBNP levels in patients with stable coronary artery disease. Clin Chim Acta. 2013; 422: 15-20. doi: 10.1016/j.cca.2013.03.025 PMID: 23566928
16. Nordenskjold AM, Ahlstrom H, Eggers KM, Frobert O, Jaffe AS, Venge P, et al. Short-and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin Chem. 2013; 59: 401-409. doi: 10.1373/clinchem.2012.191700 PMID: 23143329
17. Annual report SWEDEHEART 2012. Scand Cardiovasc J. 2014; 48 Suppl 63: 2-133. doi: 10.3109/14017431.2014.931551 PMID: 25119891
18. Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies. A classification system. Circulation. 1960; 21: 1160-1175. PMID: 13849070
19. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002; 105: 539-542. PMID: 11815441
20. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation. 1975; 51: 5-40. PMID: 1116248
21. Falk E. Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. Am J Cardiol. 1989; 63: 114E-120E. PMID: 2646888
22. Mann J, Davies MJ. Mechanisms of progression in native coronary artery disease: Role of healed plaque disruption. Heart. 1999; 82: 265-268. PMID: 10455072
23. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, et al. Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation. 2001; 103: 934-940. PMID: 11181466
24. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995; 92: 657-671. PMID: 7634481
25. Lichtlen PR, Nikutta P, Jost S, Deckers J, Wiese B, Rafflenbeul W. Anatomical progression of coronary artery disease in humans as seen by prospective, repeated, quantitated coronary angiography. Relation to clinical events and risk factors. The INTACT Study Group. Circulation. 1992; 86: 828-838. PMID: 1516195
26. Jost S, Nikutta P, Deckers JW, Wiese B. Association between coronary angiograms and cardiac events-A prospective 3-year follow-up. INTACT-Investigators. International Nifedipine Trial on Antiatherosclerotic Therapy. Int J Cardiol. 1998; 65: 271-279. PMID: 9740484
27. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol. 2008; 52: 523-527. doi: 10.1016/j.jacc.2008.04. 050 PMID: 18687244
28. Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, Kanaya T, et al. Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism. Circulation. 2015; 132: 241-250. doi: 10.1161/CIRCULATIONAHA.114.015134 PMID: 26216084
29. Baron T, Hambraeus K, Sundstrom J, Erlinge D, Jernberg T, Lindahl B, et al. Type 2 myocardial infarction in clinical practice. Heart. 2015; 101: 101-106. doi: 10.1136/heartjnl-2014-306093 PMID: 25331532
30. Task Force M, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013; 34: 2949-3003. doi: 10.1093/eurheartj/eht296 PMID: 23996286
31. Beatty AL, Ku IA, Bibbins-Domingo K, Christenson RH, DeFilippi CR, Ganz P, et al. Traditional Risk Factors Versus Biomarkers for Prediction of Secondary Events in Patients With Stable Coronary Heart Disease: From the Heart and Soul Study. J Am Heart Assoc. 2015; 4.
32. Locca D, Bucciarelli-Ducci C, Ferrante G, La Manna A, Keenan NG, Grasso A, et al. New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv. 2010; 3: 950-958. doi: 10.1016/j.jcin.2010.06.015 PMID: 20850095
33. Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R, Hueb W, et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: A collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med. 2014; 174: 232-240. doi: 10.1001/jamainternmed.2013.12855 PMID: 24296791